Trial intelligence / Profile preview

Ambroxol Lozenges for Sore Throat in Acute Viral Pharyngitis

NCT00525044Phase 3Completed

Sponsor
Boehringer Ingelheim
Start
Aug 2007
Primary completion
Jan 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of ambroxol in acute viral pharyngitis, sponsored by Boehringer Ingelheim. Started Aug 2007; status: completed.

02

Drugs

ambroxol
03

Conditions

acute viral pharyngitis

Beyond the preview

Go deeper on NCT00525044.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00525044.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call